📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-20 17:23
144 analysed today
144
Today
136,664
All-time analysed
40,493
Positive
6,319
Negative
81,911
Neutral
7,873
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
BCC Fuba Allotted ₹5 Cr in 7% Optionally Convertible Debentures of Subsidiary IOGEMS
BCC Fuba India Limited has been allotted ₹5.00 crore worth of 7% Optionally Convertible Debentures (OCDs) issued by its subsidiary company, IOGEMS Technologies Private Limited, under a second tranche private placement. The unsecured OCDs were allotted on August 18, 2026, at a face value of ₹10 each with a 7-year maturity and an annual coupon of 7%. BCC Fuba retains the option to convert the OCDs into equity shares of the subsidiary anytime prior to maturity at a price determined by a registered valuer. The ₹5.00 crore deployment represents approximately 10.9% of BCC Fuba's net worth of ₹46 crore.
Confidence: HIGH
What changedBCC Fuba has completed a ₹5 crore subscription and allotment of 7-year, 7% OCDs in its subsidiary IOGEMS Technologies.
Why it mattersThe capital infusion supports subsidiary operations while locking in a 7% annual yield for the parent company, with optionality to convert into equity as the subsidiary scales.
Investment Amount: ₹5,00,00,000Coupon Rate: 7% per annumTenure: 7 yearsAllotment Date: 18th August, 2026Investment vs Parent Net Worth: ~10.9%
📅 Short termRoutine inter-group capital deployment; no immediate impact expected on quarterly operating performance.
📈 Long termProvides long-term funding to the subsidiary with equity upside potential upon future conversion.
⚠ Risk flags
- Debentures are unsecured
- Return on investment depends on the operational execution of subsidiary IOGEMS Technologies
Key Highlights
Allotment of ₹5.00 crore in 7% unsecured OCDs of subsidiary IOGEMS Technologies Private Limited
Instrument features a 7-year tenure with an annual interest payout of 7%
Allotment executed on August 18, 2026, at an issue price of ₹10 per OCD (Second Tranche)
Parent holds the right to convert OCDs into subsidiary equity shares anytime before maturity based on registered valuer pricing
👀 What to Watch
Track the business growth and operational updates from subsidiary IOGEMS Technologies along with its impact on consolidated financials in upcoming quarterly results.
192% YoY Profit Growth: BCC Fuba Reports Strong Q1 FY27 Results with ₹25.2 Cr Revenue
BCC Fuba reported a robust performance for Q1 FY27, with standalone revenue growing 62.6% YoY to ₹25.20 crore. Net profit surged 192% YoY to ₹3.86 crore, significantly aided by a ₹1.67 crore price revision agreement with customers. The company's core Printed Circuit Board (PCB) segment remains the primary driver, contributing ₹25.05 crore to revenue. While the new Electronics Manufacturing Services (EMS) segment is currently loss-making at the EBIT level, overall profitability improved substantially compared to previous quarters.
Confidence: HIGH
What changedBCC Fuba has delivered a significant earnings beat, driven by both volume growth in PCBs and successful price renegotiations with clients.
Why it mattersThe results demonstrate strong demand in the domestic PCB market and the company's ability to pass on costs, which is critical for a small-cap player in the electronics hardware space.
Standalone Revenue (Q1): ₹25.20 CrStandalone PAT (Q1): ₹3.86 CrPrice Revision Benefit: ₹1.67 CrRevenue vs TTM Revenue: ~34.5%YoY Revenue Growth: 62.6%
📅 Short termThe stock is likely to react positively to the sharp jump in EPS (₹2.06 for the quarter vs ₹0.86 YoY) and the successful price adjustments.
📈 Long termThe company is well-positioned to benefit from the 'Make in India' push in electronics, though long-term success depends on scaling the EMS segment and maintaining PCB margins.
⚠ Risk flags
- EMS segment is currently loss-making (₹18.65 lakh loss at segment level)
- Significant portion of profit growth (₹1.67 Cr) is from a retroactive price revision
Key Highlights
Standalone Net Profit jumped 192% YoY to ₹3.86 crore from ₹1.32 crore in the same quarter last year.
Revenue from operations increased 62.6% YoY to ₹25.20 crore, representing ~34.5% of the previous TTM revenue.
Recognized ₹1.67 crore in additional revenue during the quarter due to finalized price revisions with customers.
PCB segment revenue reached ₹25.05 crore, while the nascent EMS segment contributed ₹21.38 lakhs.
Paid-up share capital increased to ₹19.82 crore from ₹17.61 crore in March 2026, following equity issuance.
👀 What to Watch
Investors should monitor the sustainability of margins in upcoming quarters without the one-time price revision benefit and track the break-even timeline for the new EMS segment.
174% YoY PAT Growth in Q1 FY27; Revenue up 63% to ₹25.27 Cr
BCC Fuba India reported a strong start to FY27 with consolidated revenue growing 63% YoY to ₹25.27 Cr. Consolidated Net Profit surged 174% YoY to ₹3.62 Cr, significantly aided by a ₹1.67 Cr one-time revenue recognition from retroactive price revisions with customers. The core Printed Circuit Board (PCB) segment remains the primary driver, while the new Electronics Manufacturing Services (EMS) segment contributed its first meaningful revenue of ₹0.21 Cr, albeit with a segment loss of ₹18.65 Lakhs.
Confidence: HIGH
What changedThe company reported a sharp jump in quarterly profitability and confirmed the initial scale-up of its new Electronics Manufacturing Services (EMS) business line.
Why it mattersThe results demonstrate strong demand in the PCB segment and the company's ability to successfully negotiate price revisions, though the EMS segment is still in its gestation phase.
Consolidated Revenue (Q1 FY27): ₹25.27 CrConsolidated PAT (Q1 FY27): ₹3.62 CrPrice Revision Benefit: ₹1.67 CrQuarterly Revenue vs TTM Revenue: ~34.6%EMS Segment Loss: ₹18.65 Lakhs
📅 Short termThe stock is likely to react positively to the significant jump in EPS and revenue, which exceeds the previous quarterly run rate.
📈 Long termThe company is successfully transitioning toward its goal of becoming a self-reliant manufacturing hub, with the EMS segment providing a secondary growth lever alongside its established PCB business.
⚠ Risk flags
- One-time revenue boost from price revisions (₹1.67 Cr) inflated current quarter profits
- EMS segment is currently loss-making
- High dependency on imported machinery
Key Highlights
Consolidated revenue increased 63% YoY to ₹25.27 Cr from ₹15.50 Cr in June 2025.
Consolidated Net Profit rose 174% YoY to ₹3.62 Cr compared to ₹1.32 Cr in the previous year's quarter.
Recognized ₹1.67 Cr in additional revenue during the quarter due to finalized price revisions with customers.
The EMS segment contributed ₹21.38 Lakhs to revenue, up from ₹6.27 Lakhs in the preceding March quarter.
Standalone EPS improved to ₹2.06 from ₹0.86 in the year-ago period.
👀 What to Watch
Monitor the sustainability of operating margins in upcoming quarters without the one-time price revision benefit, and track the path to profitability for the new EMS segment.
174% YoY PAT Growth to ₹3.62 Cr in Q1 FY27; Revenue Surges 63% YoY
BCC Fuba India reported a robust Q1 FY27 with consolidated revenue rising 63% YoY to ₹25.27 Cr and Net Profit surging 174% YoY to ₹3.62 Cr. The performance was significantly aided by a ₹1.67 Cr one-time revenue recognition following finalized price revisions with customers. The core Printed Circuit Board (PCB) segment remains the primary growth engine, while the nascent Electronics Manufacturing Services (EMS) segment reported a small loss of ₹0.18 Cr.
Confidence: HIGH
What changedThe company has successfully implemented price revisions with customers and is seeing the revenue impact of its expanded asset base in the PCB segment.
Why it mattersThe sharp growth in revenue and profitability validates the company's strategy to capture a larger share of the Indian PCB market, which is benefiting from domestic electronics manufacturing tailwinds.
Consolidated Revenue (Q1 FY27): ₹25.27 CrConsolidated PAT (Q1 FY27): ₹3.62 CrPrice Revision Revenue Impact: ₹1.67 CrQ1 Revenue vs TTM Revenue: 34.6%PCB Segment Revenue: ₹25.05 Cr
📅 Short termThe stock is likely to react positively to the substantial jump in EPS and the successful pass-through of costs via price revisions.
📈 Long termThe company's focus on HDI and flexible circuits, combined with a growing domestic PCB market, provides a structural growth runway, though high valuation (P/E 63.9) requires consistent execution.
⚠ Risk flags
- One-off revenue contribution from price revisions
- Losses in the new EMS segment
- High dependency on imported machinery
Key Highlights
Consolidated Revenue increased 63% YoY to ₹25.27 Cr from ₹15.50 Cr in June 2025.
Net Profit (PAT) grew 174% YoY to ₹3.62 Cr compared to ₹1.32 Cr in the previous year's quarter.
Recognized ₹1.67 Cr in additional revenue during the quarter due to finalized price revisions with customers.
PCB segment assets expanded significantly to ₹92.43 Cr from ₹48.55 Cr in the year-ago period.
Basic EPS for the quarter stood at ₹1.99, more than doubling from ₹0.86 in Q1 FY26.
👀 What to Watch
Watch for the sustainability of operating margins in upcoming quarters without the one-off price revision benefit. Monitor the scaling of the EMS segment to see if it can reach break-even and contribute to the bottom line.
BCC Fuba Q1 FY27: 192% YoY Profit Surge to ₹3.86 Cr; Revenue Up 63%
BCC Fuba India Ltd reported a robust Q1 FY27 with standalone revenue growing 62.6% YoY to ₹25.20 Cr and net profit jumping 192.4% to ₹3.86 Cr. The results were significantly bolstered by a ₹1.67 Cr additional revenue recognition following finalized price revisions with customers. While the core Printed Circuit Board (PCB) segment remains highly profitable, the nascent Electronics Manufacturing Services (EMS) segment contributed a modest ₹0.21 Cr in revenue with a segment loss of ₹0.18 Cr. The company maintained a healthy balance sheet with no deviations in the utilization of recent equity issuance proceeds.
Confidence: HIGH
What changedThe company has successfully implemented price revisions with customers and is beginning to report revenue from its new Electronics Manufacturing Services (EMS) segment.
Why it mattersThe sharp growth in revenue and profitability validates the company's strategy to capture a larger share of the domestic PCB market, which is projected to grow significantly by 2030. The margin expansion suggests improved pricing power and operational efficiency.
Q1 Standalone Revenue: ₹25.20 CrQ1 Standalone PAT: ₹3.86 CrPrice Revision Revenue Impact: ₹1.67 CrYoY Revenue Growth: 62.6%Q1 Basic EPS: ₹2.06EMS Segment Revenue: ₹0.21 Cr
📅 Short termThe stock is likely to react positively to the substantial YoY growth in both top-line and bottom-line, despite the one-off nature of the price revision catch-up.
📈 Long termThe company is well-positioned in the growing Indian electronics ecosystem. Long-term value depends on successfully transitioning to high-margin HDI circuits and scaling the EMS business to profitability.
⚠ Risk flags
- One-time revenue boost from price revisions
- Loss-making EMS segment
- Dependency on imported machinery for manufacturing
Key Highlights
Standalone Revenue increased 62.6% YoY to ₹25.20 Cr from ₹15.50 Cr in Q1 FY26.
Net Profit surged 192.4% YoY to ₹3.86 Cr, compared to ₹1.32 Cr in the same quarter last year.
Recognized ₹1.67 Cr in additional revenue during the quarter due to finalized customer price revisions.
PCB segment EBIT grew 155% YoY to ₹5.54 Cr, reflecting strong operational leverage.
Paid-up share capital rose to ₹19.82 Cr from ₹17.61 Cr sequentially, following equity issuance.
👀 What to Watch
Investors should monitor the sustainability of the improved margins once the one-time price revision impact (₹1.67 Cr) normalizes. Key execution milestones to watch include the scale-up of the EMS segment and progress in high-end HDI/flexible circuit manufacturing.
